vs

Side-by-side financial comparison of Empire State Realty Trust, Inc. (ESRT) and OMNICELL, INC. (OMCL). Click either name above to swap in a different company.

OMNICELL, INC. is the larger business by last-quarter revenue ($309.9M vs $190.3M, roughly 1.6× Empire State Realty Trust, Inc.). OMNICELL, INC. runs the higher net margin — 3.7% vs 1.6%, a 2.1% gap on every dollar of revenue. On growth, OMNICELL, INC. posted the faster year-over-year revenue change (14.9% vs 5.7%). Over the past eight quarters, OMNICELL, INC.'s revenue compounded faster (5.8% CAGR vs 0.2%).

Empire State Realty Trust is a leading real estate investment trust that owns, manages, and operates a portfolio of premium commercial, residential, and retail properties primarily in the New York City metropolitan area, including the iconic Empire State Building. It serves corporate tenants, retail partners, and residential occupants, focusing on sustainable property operations and long-term asset value growth.

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

ESRT vs OMCL — Head-to-Head

Bigger by revenue
OMCL
OMCL
1.6× larger
OMCL
$309.9M
$190.3M
ESRT
Growing faster (revenue YoY)
OMCL
OMCL
+9.2% gap
OMCL
14.9%
5.7%
ESRT
Higher net margin
OMCL
OMCL
2.1% more per $
OMCL
3.7%
1.6%
ESRT
Faster 2-yr revenue CAGR
OMCL
OMCL
Annualised
OMCL
5.8%
0.2%
ESRT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ESRT
ESRT
OMCL
OMCL
Revenue
$190.3M
$309.9M
Net Profit
$3.0M
$11.4M
Gross Margin
45.3%
Operating Margin
15.5%
60.1%
Net Margin
1.6%
3.7%
Revenue YoY
5.7%
14.9%
Net Profit YoY
-73.7%
EPS (diluted)
$0.20
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESRT
ESRT
OMCL
OMCL
Q1 26
$190.3M
$309.9M
Q4 25
$199.2M
$314.0M
Q3 25
$197.7M
$310.6M
Q2 25
$191.3M
$290.6M
Q1 25
$180.1M
$269.7M
Q4 24
$197.6M
$306.9M
Q3 24
$199.6M
$282.4M
Q2 24
$189.5M
$276.8M
Net Profit
ESRT
ESRT
OMCL
OMCL
Q1 26
$3.0M
$11.4M
Q4 25
$32.2M
Q3 25
$13.6M
$5.5M
Q2 25
$11.4M
$5.6M
Q1 25
$15.8M
$-7.0M
Q4 24
$18.8M
Q3 24
$22.8M
$8.6M
Q2 24
$28.6M
$3.7M
Gross Margin
ESRT
ESRT
OMCL
OMCL
Q1 26
45.3%
Q4 25
41.5%
Q3 25
43.3%
Q2 25
43.9%
Q1 25
41.1%
Q4 24
46.2%
Q3 24
43.3%
Q2 24
41.3%
Operating Margin
ESRT
ESRT
OMCL
OMCL
Q1 26
15.5%
60.1%
Q4 25
17.8%
0.1%
Q3 25
19.9%
2.7%
Q2 25
18.4%
2.8%
Q1 25
14.3%
-4.3%
Q4 24
21.7%
4.0%
Q3 24
22.7%
2.3%
Q2 24
20.8%
1.2%
Net Margin
ESRT
ESRT
OMCL
OMCL
Q1 26
1.6%
3.7%
Q4 25
16.1%
Q3 25
6.9%
1.8%
Q2 25
6.0%
1.9%
Q1 25
8.8%
-2.6%
Q4 24
9.5%
Q3 24
11.4%
3.1%
Q2 24
15.1%
1.3%
EPS (diluted)
ESRT
ESRT
OMCL
OMCL
Q1 26
$0.20
$0.25
Q4 25
$0.11
$-0.05
Q3 25
$0.05
$0.12
Q2 25
$0.04
$0.12
Q1 25
$0.05
$-0.15
Q4 24
$0.07
$0.34
Q3 24
$0.08
$0.19
Q2 24
$0.10
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESRT
ESRT
OMCL
OMCL
Cash + ST InvestmentsLiquidity on hand
$68.8M
$239.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.8B
$1.3B
Total Assets
$4.4B
$2.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESRT
ESRT
OMCL
OMCL
Q1 26
$68.8M
$239.2M
Q4 25
$132.7M
$196.5M
Q3 25
$154.1M
$180.1M
Q2 25
$94.6M
$399.0M
Q1 25
$187.8M
$386.8M
Q4 24
$385.5M
$369.2M
Q3 24
$421.9M
$570.6M
Q2 24
$535.5M
$556.8M
Stockholders' Equity
ESRT
ESRT
OMCL
OMCL
Q1 26
$1.8B
$1.3B
Q4 25
$1.1B
$1.2B
Q3 25
$1.0B
$1.2B
Q2 25
$1.0B
$1.3B
Q1 25
$1.0B
$1.3B
Q4 24
$1.0B
$1.2B
Q3 24
$1.0B
$1.2B
Q2 24
$1.0B
$1.2B
Total Assets
ESRT
ESRT
OMCL
OMCL
Q1 26
$4.4B
$2.0B
Q4 25
$4.5B
$2.0B
Q3 25
$4.1B
$1.9B
Q2 25
$4.1B
$2.1B
Q1 25
$4.1B
$2.2B
Q4 24
$4.5B
$2.1B
Q3 24
$4.4B
$2.3B
Q2 24
$4.4B
$2.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESRT
ESRT
OMCL
OMCL
Operating Cash FlowLast quarter
$54.5M
Free Cash FlowOCF − Capex
$38.6M
FCF MarginFCF / Revenue
12.5%
Capex IntensityCapex / Revenue
10.0%
Cash ConversionOCF / Net Profit
4.80×
TTM Free Cash FlowTrailing 4 quarters
$110.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESRT
ESRT
OMCL
OMCL
Q1 26
$54.5M
Q4 25
$249.1M
$30.4M
Q3 25
$105.3M
$28.3M
Q2 25
$26.7M
$42.8M
Q1 25
$83.1M
$25.9M
Q4 24
$260.9M
$56.3M
Q3 24
$102.8M
$22.8M
Q2 24
$37.1M
$58.7M
Free Cash Flow
ESRT
ESRT
OMCL
OMCL
Q1 26
$38.6M
Q4 25
$50.6M
$22.6M
Q3 25
$72.8M
$18.5M
Q2 25
$-55.1M
$31.0M
Q1 25
$41.1M
$14.8M
Q4 24
$88.0M
$47.2M
Q3 24
$-65.1M
$13.9M
Q2 24
$19.5M
$49.1M
FCF Margin
ESRT
ESRT
OMCL
OMCL
Q1 26
12.5%
Q4 25
25.4%
7.2%
Q3 25
36.8%
6.0%
Q2 25
-28.8%
10.7%
Q1 25
22.8%
5.5%
Q4 24
44.5%
15.4%
Q3 24
-32.6%
4.9%
Q2 24
10.3%
17.8%
Capex Intensity
ESRT
ESRT
OMCL
OMCL
Q1 26
10.0%
Q4 25
99.6%
2.5%
Q3 25
16.5%
3.1%
Q2 25
42.8%
4.1%
Q1 25
23.4%
4.1%
Q4 24
87.5%
3.0%
Q3 24
84.1%
3.1%
Q2 24
9.3%
3.5%
Cash Conversion
ESRT
ESRT
OMCL
OMCL
Q1 26
4.80×
Q4 25
7.74×
Q3 25
7.72×
5.18×
Q2 25
2.35×
7.58×
Q1 25
5.27×
Q4 24
13.88×
Q3 24
4.51×
2.64×
Q2 24
1.30×
15.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESRT
ESRT

Rental revenue (1)$166.1M87%
Observatory revenue$18.5M10%
Other revenue and fees$4.1M2%
Lease termination fees$1.4M1%
Third-party management and other fees$277.0K0%

OMCL
OMCL

Product revenues$174.8M56%
Service revenues$135.1M44%

Related Comparisons